Catalyst Wire Dossier Catalyst Wire Dossier

CEFIXIME

cefixime · Rising Pharma Holdings, Inc.
Drug timelines are a Plus or Pro feature.

30 regulatory and trial events tracked for CEFIXIME, covering 2007-04-10 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma [Phase 1]

See pricing